OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ten reasons gastroenterologists and hepatologists should be treating obesity
Michael Camilleri, Emad El‐Omar
Gut (2023) Vol. 72, Iss. 6, pp. 1033-1038
Closed Access | Times Cited: 7
Michael Camilleri, Emad El‐Omar
Gut (2023) Vol. 72, Iss. 6, pp. 1033-1038
Closed Access | Times Cited: 7
Showing 7 citing articles:
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion
Shang‐Chin Huang, Tung‐Hung Su, Tai‐Chung Tseng, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 581-590.e6
Closed Access | Times Cited: 26
Shang‐Chin Huang, Tung‐Hung Su, Tai‐Chung Tseng, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 581-590.e6
Closed Access | Times Cited: 26
Newer pharmacological interventions directed at gut hormones for obesity
Michael Camilleri, Andrés Acosta
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1153-1164
Closed Access | Times Cited: 14
Michael Camilleri, Andrés Acosta
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1153-1164
Closed Access | Times Cited: 14
Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice
Michael Camilleri, Camille Lupiañez-Merly
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 6, pp. 1028-1037
Closed Access | Times Cited: 11
Michael Camilleri, Camille Lupiañez-Merly
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 6, pp. 1028-1037
Closed Access | Times Cited: 11
Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction–Associated Steatotic Liver Disease: Progress But With Challenges
Alina M. Allen, Elisa Pose, K. Rajender Reddy, et al.
Gastroenterology (2023) Vol. 166, Iss. 2, pp. 229-234
Closed Access | Times Cited: 8
Alina M. Allen, Elisa Pose, K. Rajender Reddy, et al.
Gastroenterology (2023) Vol. 166, Iss. 2, pp. 229-234
Closed Access | Times Cited: 8
Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm
Paul Brennan, Shira Zelber‐Sagi, Alina M. Allen, et al.
Gut (2023), pp. gutjnl-330771
Open Access | Times Cited: 6
Paul Brennan, Shira Zelber‐Sagi, Alina M. Allen, et al.
Gut (2023), pp. gutjnl-330771
Open Access | Times Cited: 6
Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn’s Disease
P Bacsúr, T Resál, B Farkas, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2100-2100
Open Access
P Bacsúr, T Resál, B Farkas, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2100-2100
Open Access
